Fulgent Genetics Follow Verify

www.fulgentgenetics.com
Fulgent Genetics
Type	Public
Industry	Biotechnology
Founded	2011
Headquarters	Temple City, California 91780 United States
Key people	Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO)

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

• Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
• College of American Pathologists (CAP) Accreditation 2017
• California Clinical Laboratory License 2016
• Florida Clinical Laboratory License 2016 - 2018
• Pennsylvania Clinical Laboratory Permit 2016-2017
• Maryland Medical Laboratory License 2015-2016

Top 5 Recent Tweets

Date	Author	Comment
September 19, 2018	ConsumerFeed	Zacks: Fulgent Genetics Inc $FLGT Given Consensus Rating of “Hold” by Brokerages https://t.co/2pRh0vPiqo
September 17, 2018	registrarjourn	Zacks: Fulgent Genetics Inc $FLGT Receives Average Rating of “Hold” from Analysts https://t.co/b5wZPSiv5h
September 17, 2018	EnterpriseLeade	Zacks: Fulgent Genetics Inc $FLGT Receives Average Rating of “Hold” from Analysts https://t.co/taOchdnHWv
September 14, 2018	registrarjourn	Fulgent Genetics $FLGT Earning Somewhat Positive Media Coverage, Study Shows https://t.co/u3PuKAlhvd

Top 5 Lifetime News Headlines

Top Authors

• Archana Sinha
• View all authors

Verification history

• 691 days ago


• View all verifications